XML 91 R88.htm IDEA: XBRL DOCUMENT v3.20.1
Business Combinations - Cost, FV of Assets, Goodwill and Other (Details)
€ in Thousands, $ in Thousands
 1 Months Ended 8 Months Ended 12 Months Ended
Apr. 30, 2019
EUR (€)
Jan. 26, 2018
USD ($)
Jan. 12, 2018
EUR (€)
Jun. 30, 2018
EUR (€)
m²
employee
Center
item
l
Dec. 31, 2019
EUR (€)
Dec. 31, 2019
EUR (€)
Dec. 31, 2018
EUR (€)
Dec. 31, 2017
EUR (€)
l
Dec. 31, 2016
EUR (€)
May 31, 2019
EUR (€)
Apr. 30, 2019
USD ($)
Apr. 30, 2019
EUR (€)
Dec. 31, 2018
USD ($)
Center
Dec. 31, 2018
EUR (€)
Center
Dec. 28, 2018
USD ($)
Dec. 01, 2018
EUR (€)
Aug. 31, 2018
EUR (€)
Aug. 01, 2018
USD ($)
Center
Aug. 01, 2018
EUR (€)
Center
Mar. 19, 2018
EUR (€)
Jan. 26, 2018
EUR (€)
Jul. 25, 2017
EUR (€)
Jun. 01, 2017
Feb. 28, 2017
USD ($)
Feb. 28, 2017
EUR (€)
Jan. 31, 2017
USD ($)
Jan. 31, 2017
EUR (€)
Dec. 31, 2016
USD ($)
Dec. 27, 2016
USD ($)
Center
Dec. 14, 2016
USD ($)
May 11, 2016
USD ($)
Center
item
May 11, 2016
EUR (€)
Center
item
Sep. 30, 2014
EUR (€)
Biotest Us Corporation and Haema AG                                                                  
Other disclosures:                                                                  
Consideration for sale of subsidiary | $                             $ 538,014                                    
Plasma Donor Centers                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Payment in cash                   € 20,500                                              
Fair value of net assets acquired                   1,620                                              
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)                   18,880                                              
Total business combination cost                   20,500                                              
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date                   € 1,396                                              
Interstated Blood Bank, Inc. Group                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Payment in cash                     $ 100,000 € 88,984                                     $ 100,000 € 88,215  
Purchase price for the remaining stakes | $                                                             100,000    
Fair value of the previous investment in the company                     105,779 94,126                                          
Fair value of the call option                     10,000 8,898                                          
Fair value of net assets acquired                     21,744 19,345                                          
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)                     194,035 172,663                                          
Total business combination cost                     100,000 88,984                                          
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date                     $ 26,661 € 23,724                                          
Agreed payment amount for call option                                                             $ 10,000 € 9,007  
Number of blood donation centers | Center                                                             9 9  
Number of plasma collection centers | Center                                                             26 26  
Number of laboratories | item                                                             1 1  
Increase (decrease) in combined revenue had the acquisition taken place on January 1           € 10,146                                                      
Increase (decrease) in combined profit had the acquisition taken place on January 1           (1,436)                                                      
Revenue of acquiree since acquisition date         € 13,364                                                        
Profit of acquiree since acquisition date         € 280                                                        
Variation between the fair value of the previous investment and the book value € 4,521                                                                
Interstate Blood Bank, Inc                                                                  
Other disclosures:                                                                  
Ownership interest acquired (as a percent)                                                             49.19% 49.19%  
Bio Blood Components Inc.                                                                  
Other disclosures:                                                                  
Ownership interest acquired (as a percent)                                                             48.97% 48.97%  
Plasma Biological Services, LLC.                                                                  
Other disclosures:                                                                  
Ownership interest acquired (as a percent)                                                             48.90% 48.90%  
Biotest Acquisition                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Fair value of net assets acquired                                   $ 133,761 € 114,463                            
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)                                   152,693 130,663                            
Total business combination cost                                   286,454 245,126                            
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date                                   $ 25,931 € 22,190                            
Number of plasma collection centers | Center                                   24 24                            
Ownership interest acquired (as a percent)                                   100.00% 100.00%                            
Plasma collected in preceding financial year (in litres) | l               850,000                                                  
Increase (decrease) in combined revenue had the acquisition taken place on January 1             € 90,216                                                    
Increase (decrease) in combined profit had the acquisition taken place on January 1             5,592                                                    
Revenue of acquiree since acquisition date             73,747                                                    
Profit of acquiree since acquisition date             7,473                                                    
Kedplasma Centers                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Payment in cash                         $ 50,163 € 42,780   € 21,841 € 20,939                                
Fair value of net assets acquired                         5,787 5,042                                      
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)                         44,376 37,738                                      
Total business combination cost                         $ 50,163 42,780                                      
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date                           € 4,942                                      
Number of plasma centers owned | Center                         6 6                                      
Haema, AG                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Fair value of net assets acquired                                       € 49,057                          
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)                                       171,134                          
Total business combination cost       € 220,191                               220,191                          
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date                                       € 25,407                          
Ownership interest acquired (as a percent)       100.00%                                                          
Number of plasma centers owned | Center       35                                                          
Number of plasma collection centers under construction | Center       3                                                          
Area of headquarters (in square metre) | m²       24,000                                                          
Total number of employees | employee       1,100                                                          
Plasma collected in preceding financial year (in litres) | l       800,000                                                          
Number of plasma donations collected | item       1,000,000                                                          
Increase (decrease) in combined revenue had the acquisition taken place on January 1             39,517                                                    
Revenue of acquiree since acquisition date             46,758                                                    
Profit of acquiree since acquisition date             € 53                                                    
Goetech, LLC. ("MedKeeper")                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Fair value of net assets acquired   $ 17,207                                     € 14,104                        
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)   67,492                                     55,321                        
First repurchase of non-controlling interests   14,000                                     11,475                        
Second repurchase of non-controlling interests (discounted amount)   18,241                                     14,952                        
Purchase of remaining non-controlling interests   52,458                                     42,998                        
Total business combination cost   84,699                                     69,425                        
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date   82                                     € 67                        
Share capital increase | $   $ 98,000                                                              
Ownership interest acquired (as a percent)   51.00%                                     51.00%                        
Ownership in subsidiary (as a percent)   51.00%                                                              
Repurchase of own shares from noncontrolling shareholder in 2 business days | $   $ 14,000                                                              
Repurchase of own shares from noncontrolling shareholder in two years | $   $ 20,000                                                              
Option to purchase remaining voting rights, term (in years)   3 years                                                              
Revenue of acquiree since acquisition date           9,210                                                      
Profit of acquiree since acquisition date           € 1,778                                                      
Aigues Minerals de Vilajuiga S. A.                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Total business combination cost     € 550                                                            
Other disclosures:                                                                  
Ownership interest acquired (as a percent)     50.00%                                       50.00%                    
Ownership in subsidiary (as a percent)     100.00%                                                            
Hologic acquisition                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Payment in cash                                                   $ 1,865,000 € 1,734,077     $ 1,865,000      
Fair value of net assets acquired                                                   332,923 309,551            
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)                                                   1,577,134 1,466,420            
Result of the cancellation of the existing contract                                                   45,057 41,894            
Total business combination cost                                                   1,910,057 1,775,971            
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date                                                   $ 26,424 € 24,569            
Expenses incurred for acquisition               € 13,000 € 5,100                                                
Kiro Grifols S.L (formerly Kiro Robotics S.L)                                                                  
Other disclosures:                                                                  
Share capital increase                                                                 € 21,000
Ownership interest acquired (as a percent)                                           40.00%                     50.00%
Additional ownership interest acquired, consideration transferred                                           € 12,800                      
Ownership in subsidiary (as a percent)           90.00%                                                      
Kiro Grifols S.L (formerly Kiro Robotics S.L) | Socios Fundadores Kiro, S.L.                                                                  
Other disclosures:                                                                  
Ownership in subsidiary held by noncontrolling interests (as a percent)           10.00%                                                      
Kedplamsa acquisition                                                                  
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill:                                                                  
Payment in cash                                               $ 47,083 € 44,238       $ 47,000        
Fair value of net assets acquired                                               4,403 4,137                
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired)                                               42,680 40,101                
Total business combination cost                                               $ 47,083 44,238                
Other disclosures:                                                                  
Property, plant and equipment recognised as of acquisition date                                                 € 3,698                
Number of Plasma Donor Centers acquired | Center                                                         6        
Advance paid for acquisition | $                                                       $ 15,000